Published in J Cereb Blood Flow Metab on January 20, 2010
Repetitive hypoxia extends endogenous neurovascular protection for stroke. Ann Neurol (2011) 1.24
Noninvasive molecular imaging of neuroinflammation. J Cereb Blood Flow Metab (2012) 1.19
Molecular MRI enables early and sensitive detection of brain metastases. Proc Natl Acad Sci U S A (2012) 1.10
Neuroinflammation after intracerebral hemorrhage. Front Cell Neurosci (2014) 1.05
CMR for characterization of the myocardium in acute coronary syndromes. Nat Rev Cardiol (2010) 1.04
Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation. AJR Am J Roentgenol (2015) 0.91
Molecular magnetic resonance imaging of angiogenesis in vivo using polyvalent cyclic RGD-iron oxide microparticle conjugates. Theranostics (2015) 0.88
Molecular magnetic resonance imaging of brain-immune interactions. Front Cell Neurosci (2014) 0.88
Immunological profile of silent brain infarction and lacunar stroke. PLoS One (2013) 0.86
Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases. J Control Release (2012) 0.85
Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases. Nanomedicine (2015) 0.82
Cardiac magnetic resonance imaging of rapid VCAM-1 up-regulation in myocardial ischemia-reperfusion injury. Eur Biophys J (2012) 0.80
Soluble Epoxide Hydrolase in Hydrocephalus, Cerebral Edema, and Vascular Inflammation After Subarachnoid Hemorrhage. Stroke (2015) 0.79
Label-free CEST MRI Detection of Citicoline-Liposome Drug Delivery in Ischemic Stroke. Theranostics (2016) 0.79
MRI/MRS in neuroinflammation: methodology and applications. Clin Transl Imaging (2015) 0.77
Imaging Neuroinflammation - from Bench to Bedside. J Clin Cell Immunol (2014) 0.77
Covalent assembly of nanoparticles as a peptidase-degradable platform for molecular MRI. Nat Commun (2017) 0.75
MR diffusion tensor spectroscopy and imaging. Biophys J (1994) 22.78
A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A (1999) 3.96
Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet (2003) 3.36
Role of angiogenesis in patients with cerebral ischemic stroke. Stroke (1994) 2.96
Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol (2003) 2.57
Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J Clin Invest (1996) 2.19
Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J (2009) 1.95
IL-10 reduces rat brain injury following focal stroke. Neurosci Lett (1998) 1.90
In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nat Med (2007) 1.90
Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler Thromb Vasc Biol (2007) 1.78
The harms and benefits of inflammatory and immune responses in vascular disease. Stroke (2006) 1.63
A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging. J Cereb Blood Flow Metab (1998) 1.58
Correction of motional artifacts in diffusion-weighted MR images using navigator echoes. Magn Reson Imaging (1994) 1.54
'Ischemic tolerance' phenomenon detected in various brain regions. Brain Res (1991) 1.51
Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation. Brain Pathol (2000) 1.50
Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke (1995) 1.27
Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. Circ Res (1997) 1.24
Preconditioning suppresses inflammation in neonatal hypoxic ischemia via Akt activation. Stroke (2007) 1.24
The role of cytokines in the neuropathology of stroke and neurotrauma. Neuroimmunomodulation (1998) 1.22
Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci (1996) 1.16
Prevention of inflammation is a mechanism of preconditioning-induced neuroprotection against focal cerebral ischemia. Neurochem Int (2006) 1.15
Injuries to the vascular endothelium: vascular wall and endothelial dysfunction. Rev Neurol Dis (2008) 1.15
Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T. Neurosci Lett (2005) 1.09
Temperature-regulated model of focal ischemia in the mouse: a study with histopathological and behavioral outcomes. Stroke (2004) 1.09
Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice. J Cereb Blood Flow Metab (2006) 1.08
Improved regional cerebral blood flow is important for the protection seen in a mouse model of late phase ischemic preconditioning. Brain Res (2006) 1.06
The expression of P- and E-selectins in three models of middle cerebral artery occlusion. Brain Res (1998) 1.05
Postischemic cerebrovascular E-selectin expression mediates tissue injury in murine stroke. Stroke (2000) 1.03
Deficiency of intercellular adhesion molecule 1 attenuates microcirculatory disturbance and infarction size in focal cerebral ischemia. J Cereb Blood Flow Metab (1998) 1.03
Ischemic stroke intervention requires mixed cellular protection of the penumbra. Curr Opin Investig Drugs (2009) 1.01
In vivo imaging of the inflammatory receptor CD40 after cerebral ischemia using a fluorescent antibody. Stroke (2008) 0.99
Inflammation markers and prediction of post-stroke vascular disease recurrence: the MITICO study. J Neurol (2009) 0.99
Caspase-dependent and caspase-independent signalling of apoptosis in the penumbra following middle cerebral artery occlusion in the adult rat. Neuropathol Appl Neurobiol (2003) 0.97
Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia. Stroke (1992) 0.94
MR molecular imaging of early endothelial activation in focal ischemia. Ann Neurol (2004) 0.90
Induced expression of adhesion molecules following focal brain ischemia. J Neurotrauma (1995) 0.84
High resolution MRI and MRS: a feasibility study for the investigation of focal cerebral ischemia in mice. NMR Biomed (1998) 0.80
Preconditioning in vivo ischemia inhibits anoxic long-term potentiation and functionally protects CA1 neurons in the gerbil. J Cereb Blood Flow Metab (1998) 0.79
Glial and neuronal control of brain blood flow. Nature (2010) 6.61
Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol (2007) 3.72
The exact science of stroke thrombolysis and the quiet art of patient selection. Brain (2013) 3.33
Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice. Arterioscler Thromb Vasc Biol (2004) 2.53
Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke (2005) 2.50
Expanding the diversity of chemical protein modification allows post-translational mimicry. Nature (2007) 2.45
Myocardial oxygenation in coronary artery disease: insights from blood oxygen level-dependent magnetic resonance imaging at 3 tesla. J Am Coll Cardiol (2012) 2.38
Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ (2005) 2.36
Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 2.34
Reliability of assessing percentage of diffusion-perfusion mismatch. Stroke (2003) 2.22
Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A (2002) 2.13
Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke (2004) 2.13
Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke (2003) 2.12
Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry. Stroke (2006) 2.04
Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson (2012) 2.03
Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index. Circ Cardiovasc Imaging (2011) 1.97
Intravenous thrombolysis for acute ischaemic stroke in young adult patients. Can J Neurol Sci (2009) 1.95
In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nat Med (2007) 1.90
Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience. Age Ageing (2004) 1.90
Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy. Nat Med (2013) 1.89
Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study. Stroke (2006) 1.86
Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla. J Am Coll Cardiol (2007) 1.86
The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab (2004) 1.80
Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler Thromb Vasc Biol (2007) 1.78
Assessing research impact in academic clinical medicine: a study using Research Excellence Framework pilot impact indicators. BMC Health Serv Res (2012) 1.76
Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry. Cerebrovasc Dis (2010) 1.74
The gender effect in stroke thrombolysis: of CASES, controls, and treatment-effect modification. Neurology (2008) 1.73
Organizational models of emerging academic health science centers in England. Acad Med (2010) 1.67
Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol (2005) 1.67
Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. J Am Coll Cardiol (2009) 1.66
Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after ST-segment elevation myocardial infarction. J Am Coll Cardiol (2014) 1.63
Selective permeabilization of the blood-brain barrier at sites of metastasis. J Natl Cancer Inst (2013) 1.56
Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatry (2006) 1.52
Complications of intracerebral haemorrhage. Lancet Neurol (2012) 1.47
Rapid evaluation after high-risk TIA is associated with lower stroke risk. Can J Neurol Sci (2009) 1.45
An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke. Int J Stroke (2008) 1.43
Stroke in the very old: clinical presentations and outcomes. Age Ageing (2008) 1.39
Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care (2009) 1.37
Neuroprotection for ischaemic stroke: translation from the bench to the bedside. Int J Stroke (2012) 1.37
Plaque features associated with increased cerebral infarction after minor stroke and TIA: a prospective, case-control, 3-T carotid artery MR imaging study. JACC Cardiovasc Imaging (2012) 1.35
Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. Am J Pathol (2005) 1.35
Neurological complications of acute ischaemic stroke. Lancet Neurol (2011) 1.32
Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease. Circulation (2012) 1.32
Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. Am J Pathol (2004) 1.31
Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am J Pathol (2004) 1.31
Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis (2003) 1.31
Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin. Atherosclerosis (2009) 1.31
Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms. Arterioscler Thromb Vasc Biol (2012) 1.29
Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab (2010) 1.27
Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies. Neurology (2014) 1.26
Form to function: current and future roles for atherosclerosis imaging in drug development. Nat Rev Drug Discov (2008) 1.26
Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson (2014) 1.26
Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease. Proc Natl Acad Sci U S A (2008) 1.26
The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation. Can J Cardiol (2003) 1.25
Motor skill learning induces changes in white matter microstructure and myelination. J Neurosci (2013) 1.25
Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ (2004) 1.22
Systemic inflammatory response reactivates immune-mediated lesions in rat brain. J Neurosci (2009) 1.21
NXY-059: brain or vessel protection. Stroke (2006) 1.20
Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis. JACC Cardiovasc Imaging (2012) 1.18
Ischemic stroke in the elderly: an overview of evidence. Nat Rev Neurol (2010) 1.15
Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia. Stroke (2005) 1.13
Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice. Circulation (2004) 1.12
Interobserver variation of ASPECTS in real time. Stroke (2004) 1.12
CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASEB J (2003) 1.11
MRI detection of early endothelial activation in brain inflammation. Magn Reson Med (2004) 1.11
Cerebral blood flow alteration in neuroprotection following cerebral ischaemia. J Physiol (2011) 1.11
Acute intravenous--intra-arterial revascularization therapy for severe ischemic stroke. Stroke (2002) 1.10
Molecular MRI enables early and sensitive detection of brain metastases. Proc Natl Acad Sci U S A (2012) 1.10
The systemic and local acute phase response following acute brain injury. J Cereb Blood Flow Metab (2002) 1.09
TNF-alpha reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFR2-dependent pathway. Brain (2002) 1.09
A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI. J Clin Invest (2008) 1.09
Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels. Circulation (2013) 1.09
Temperature-regulated model of focal ischemia in the mouse: a study with histopathological and behavioral outcomes. Stroke (2004) 1.09
An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide. Atherosclerosis (2009) 1.08
In-vivo quantitative T2 mapping of carotid arteries in atherosclerotic patients: segmentation and T2 measurement of plaque components. J Cardiovasc Magn Reson (2013) 1.06
Improved regional cerebral blood flow is important for the protection seen in a mouse model of late phase ischemic preconditioning. Brain Res (2006) 1.06
Stroke: working toward a prioritized world agenda. Stroke (2010) 1.05
Quantification and 3D reconstruction of atherosclerotic plaque components in apolipoprotein E knockout mice using ex vivo high-resolution MRI. Arterioscler Thromb Vasc Biol (2004) 1.05
Therapeutic manipulation of the HIF hydroxylases. Antioxid Redox Signal (2010) 1.05
Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Am J Pathol (2002) 1.04
CMR for characterization of the myocardium in acute coronary syndromes. Nat Rev Cardiol (2010) 1.04
Neuroprotection for stroke: current status and future perspectives. Int J Mol Sci (2012) 1.04
Reduced ventricular proliferation in the foetal cortex following maternal inflammation in the mouse. Brain (2011) 1.03